Your browser doesn't support javascript.
loading
Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease.
Forss, Anders; Clements, Mark; Myrelid, Pär; Strid, Hans; Söderman, Charlotte; Wagner, Agnieszka; Andersson, David; Hjelm, Fredrik; Olén, Ola; Halfvarson, Jonas; Ludvigsson, Jonas F.
Afiliação
  • Forss A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 171 77, Stockholm, Sweden. anders.forss@ki.se.
  • Clements M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 171 77, Stockholm, Sweden.
  • Myrelid P; Department of Biomedical and Clinical Sciences, Division of Surgery, Linköping University Hospital, Linköping University, Linköping, Sweden.
  • Strid H; Department of Internal Medicine, Södra Älvsborg Hospital, Borås, Sweden.
  • Söderman C; Medical Department, Capio St Göran Hospital, Stockholm, Sweden.
  • Wagner A; Department of Internal Medicine, Blekinge Hospital, Karlskrona, Sweden.
  • Andersson D; Department of Internal Medicine, Danderyd University Hospital, Stockholm, Sweden.
  • Hjelm F; Janssen Cilag AB, Solna, Sweden.
  • Olén O; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Halfvarson J; Sachs' Children and Youth Hospital, Stockholm South General Hospital, Stockholm, Sweden.
  • Ludvigsson JF; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Dig Dis Sci ; 68(1): 65-76, 2023 01.
Article em En | MEDLINE | ID: mdl-35459973

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn / Ustekinumab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Dig Dis Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn / Ustekinumab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Dig Dis Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia